MIFH
PPH icon

Migdal Insurance & Financial Holdings’s VanEck Pharmaceutical ETF PPH Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-905,200
Closed -$59.1M – 128
2015
Q4 		$59.1M Buy
+905,200
New +$58.5M 1.69% 13

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Migdal Insurance & Financial Holdings's PPH Position: Q1 2016 in Review

Migdal Insurance & Financial Holdings sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2016, closing a stake of 905,200 shares — an estimated $59.1M sold.

Migdal Insurance & Financial Holdings first reported a position in PPH in Q4 2015 and held it in 1 quarter. The position peaked at $59.1M in Q4 2015. 58 funds tracked by Wall St. Rank hold PPH as of Q1 2016.

  • Migdal Insurance & Financial Holdings reported no remaining VanEck Pharmaceutical ETF position as of Q1 2016 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 905,200 VanEck Pharmaceutical ETF shares in Q1 2016, an estimated $59.1M.
  • Migdal Insurance & Financial Holdings first reported a position in VanEck Pharmaceutical ETF in Q4 2015 and held it in 1 quarter.
  • Migdal Insurance & Financial Holdings's VanEck Pharmaceutical ETF position peaked at $59.1M in Q4 2015.
  • 58 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2016.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2016, filed 20 Apr 2016.